Find out more about the study on alpha-synuclein and Parkinson’s disease.
New insights on immune cell process and Parkinson’s disease
Author: Saskia MairPublished: 14 October 2021
Prep: Cook: Serves:
Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters.
The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another.
In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies.
“We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital Bonn.
Lead image credit: AG Heneka / University of Bonn
For more information on the latest Parkinson’s disease research, please visit the EPDA website.
Share this story
White blood cells could help diagnose people at risk of Parkinson’s, study finds
Scientists in the US have found additional evidence for the link between imREAD MORE
Can studying our immune systems help combat Parkinson’s?
Register for this free, hour-long webinarREAD MORE
Better balanced immune system could prevent Parkinson’s
A study, published in the journal ‘Nature’, has suggested that it may bREAD MORE